Moderna (NASDAQ: MRNA) is one of the world’s most significant pharmaceutical players, and after its latest 40% share price surge, a large number of investors are investigating the company in further detail.
If you want to invest in Moderna today, and you want to find out all of the key information you need to inform your investment, you have come to the right article. Simply scroll down to find out what the company is, what it does, why it is rising in value and what our price forecast is for Moderna stock in the coming years.
If you want to buy MRNA shares immediately, and you are looking for the best platform to use, check out the section below. Here you can find our analysts’ top two picks based on their extensive research. They are two of the best places to buy Moderna shares in the UK and elsewhere right now.
How & where to buy Moderna stock online
If you are looking for the best platform to buy, sell and trade Moderna shares, look no further than the low-free, reliable stockbrokers we have listed below.
Simply click on one of the links, sign up, deposit funds and purchase the number of MRNA shares you want to hold:
eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
What is Moderna (MRNA)?
Founded in 2010 and headquartered in Cambridge, Massachusetts, it is a biotechnology company that develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases.
It is perhaps best known for its COVID-19 vaccine, which was one of the first vaccines to receive emergency use authorisation internationally and has become instrumental in humanity’s response to the pandemic. In fact, this vaccine is the reason many commentators feel MRNA stock has surged so dramatically in recent weeks.
Quite how sustainable this growth is remains to be seen, but with many other products in the works, we wouldn’t be surprised to see this progress consolidated by further catalyst moments in the coming months.
Should I buy Moderna stock today?
Investing always carries a degree of risk, and this is especially true for biotechnology companies. The highly advanced technology being used and the rigorous testing protocols mean there are plenty of opportunities for things to go wrong.
However, if you are not averse to risk, and you want to invest in a promising company that has already proven its commercial credentials, MRNA shares may be of interest to you.
MRNA price target 2021
Our Moderna price target for 2021 and beyond is as follows: a 12-month high of $299, a median of $194, and a low of $83. The variance on display demonstrates the potential volatility that is on the horizon with a stock of this nature, though our overall outlook remains bullish.